Lisa Nolan Wright Novo Nordisk

Lisa Wright has over 10 years of experience in the pharmaceutical and biopharmaceutical space. Lisa has held various roles within industry, primarily in regulatory and regulatory policy. At Novo Nordisk she works to influence and advocate FDA in the regulatory CMC and device environment. Focus areas of her external advocacy are in advanced manufacturing, platform manufacturing technologies and combination products. Prior to working at Novo Nordisk, she worked for several different consulting companies, including Booz Allen Hamilton supporting clients at CDER and CDRH at FDA. She started her career at National Cancer Institute performing non-clinical research on tumorigenesis in keratinocytes. She has a MS in Bioinformatics from Johns Hopkins University and a BS in Biology from University of Maryland at College Park.